Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells (MSCs) represent an attractive cell type for research and therapy due to their ability to proliferate, differentiate, modulate immune reactions, and secrete trophic factors. MSCs exist in a multitude of tissues, including bone marrow, umbilical cord, and adipose tissues. Moreover, MSCs have recently been isolated from the liver. Compared with other MSC types, liver-derived human MSCs (LHMSCs) possess general morphologies, immune functions, and differentiation capacities. Interestingly, LHMCSs produce higher levels of pro-angiogenic, anti-inflammatory, and anti-apoptotic cytokines than those of bone marrow-derived MSCs. Thus, these cells may be a promising therapeutic source for liver diseases. This paper summarizes the biological characteristics of LHMSCs and their potential benefits and risks for the treatment of liver diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Michalopoulos, G. K. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21172 · Cited by 1,384
Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A., & Ratajczak, M. Z. (2006) · Leukemia · doi:10.1038/sj.leu.2404296 · Cited by 1,340 · cited 1×
“Recently, they have been recognized to carry proteins, microRNAs, and mRNAs, and to play important roles in cellto-cell communication [74].”
BackgroundInitiation of Mammalian Liver Development from Endoderm by Fibroblast Growth Factors
Jung, J., Zheng, M., Goldfarb, M., & Zaret, K. S. (1999) · Science · doi:10.1126/science.284.5422.1998 · Cited by 721
Kuo, T. K., Hung, S., Chuang, C., Chen, C., Shih, Y. V., Fang, S. Y., Yang, V. W., & Lee, O. K. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.015 · Cited by 466 · cited 1×
“Moreover, MSCs are resistant to reactive oxygen species in vitro, reduce oxidative stress in recipient mice, and accelerate repopulation of hepatocytes after liver damage [10].”
BackgroundHong, S. H., Gang, E. J., Jeong, J. A., Ahn, C., Hwang, S. H., Yang, I. H., Park, H. K., Han, H., & Kim, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.086 · Cited by 248 · cited 1×
“ITS and NTA promote the proliferation and survival of primary hepatocytes [47, 48].”
BackgroundViñas, O., Bataller, R., Sancho-Bru, P., Ginès, P., Berenguer, C., Enrich, C., Nicolás, J. M., Ercilla, G., Gallart, T., Vives, J., et al. (2003) · Hepatology · doi:10.1002/hep.1840380418 · Cited by 223 · cited 1×
“However, HSCs are positive for NCAM, CK19 and HLA-class II membrane markers [36], for which LHMSCs are negative.”
BackgroundRole of Oncostatin M in hematopoiesis and liver development
Miyajima, A., Kinoshita, T., Tanaka, M., Kamiya, A., Mukouyama, Y., & Hara, T. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00003-4 · Cited by 153 · cited 1×
“OSM is a member of the IL-6 subfamily that plays an important role in progression from hepatocyte development to liver maturation [51, 52].”
BackgroundFouraschen, S. M. G., Pan, Q., de Ruiter, P. E., Farid, W. R. R., Kazemier, G., Kwekkeboom, J., Ijzermans, J. N. M., Metselaar, H. J., Tilanus, H. W., de Jonge, J., et al. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0560 · Cited by 102 · cited 2×
“In pre-clinical experiments, the efficacy of application of LHMSCsecreted factors in 70 % hepatectomized mice suggests their potential use in patients undergoing extensive liver resection or transplantation of small liver grafts [73].”
Background
Cited by
Brennan, M. Á., Layrolle, P., & Mooney, D. J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909125 · Cited by 396
Dabrowska, S., Andrzejewska, A., Janowski, M., & Lukomska, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.591065 · Cited by 282
Dysfunctional Immune Response in Acute-on-Chronic Liver Failure: It Takes Two to Tango
Martin-Mateos, R., Alvarez-Mon, M., & Albillos, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00973 · Cited by 116
A decade of progress in liver regenerative medicine
Zhang, J., Zhao, X., Liang, L., Li, J., Demirci, U., & Wang, S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.027 · Cited by 111
“The effect 13 of soluble factors on hepatocytes has been previously reviewed [59].”
BackgroundStem cells for treatment of liver fibrosis/cirrhosis: clinical progress and therapeutic potential
Liu, P., Mao, Y., Xie, Y., Wei, J., & Yao, J. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03041-5 · Cited by 82
“Bone marrow mesenchymal stem cells BMMSCs are isolated from bone marrow mononuclear cells (BMMNCs).”
BackgroundInfluential
Metadata
- Authors
- Wang, Y., Yu, X., Chen, E., & Li, L.
- Venue
- Stem Cell Research & Therapy
- Published
- 2016-05-12
- Volume
- 7
- Issue
- 1
- Pages
- 71-71
- ISSN
- 1757-6512 (ISSN-L)
- OpenAlex
- W2367921402
- Cited by
- 77
- References
- 8
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases. https://app.cochat.ai/papers/10.1186/s13287-016-0330-3
- The paper
- Wang, Y., Yu, X., Chen, E., & Li, L. (2016). Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-016-0330-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.